Navigation Links
HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid-Beta Accumulation, a Hallmark of Alzheimer's Disease
Date:9/3/2009

NAPLES, Fla., Sept. 3 /PRNewswire/ -- Alzheimer's disease is the most common cause of dementia among the elderly and is projected to increase in prevalence over the next decades as the population ages -- creating an urgent need for treatments that will prevent or reverse the now-inexorable course of cognitive deterioration and memory loss. Because development of synthetic drugs is expensive and complex, many researchers are focusing on botanical extracts whose benefits have been documented by traditional medicine systems. In that vein, scientists with HerbalScience Group LLC, working with researchers from other organizations and medical institutions, conducted an in-depth study of optimized turmeric extracts, demonstrating that key bioactives in the botanical extracts inhibit aggregation and release of amyloid, a protein fragment considered a prime causal suspect in Alzheimer's disease.

An article detailing the study, titled "Optimized Turmeric Extracts Have Potent Anti-Amyloidogenic Effects," will be published in the December 2009 issue of Current Alzheimer's Research, a peer-reviewed scientific journal. The authors are affiliated with several research organizations and medical institutions, including HerbalScience Group LLC; the University of Miami Leonard M. Miller School of Medicine, Miami, Florida; the University of South Florida College of Medicine, Tampa, Florida; Veterans Administration Hospital, Research Service, Tampa, Florida; and Natura Therapeutics, Tampa, Florida.

"The optimized extracts outperformed curcumin, the best studied anti-Alzheimer extract from turmeric," said Randall S. Alberte, Ph.D., one of the authors of the study and Chief Scientific Officer of HerbalScience Group LLC, a Naples, Florida, and Singapore-based company dedicated to applying advanced science and technology to the production of botanical drugs and nutraceuticals.

For the res
'/>"/>

SOURCE HerbalScience Group
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. HerbalScience Research Identifies Key Bioactives in Nettle Extract That Inhibit Inflammation Associated with Seasonal Allergies
2. HerbalScience Research Identifies Specific Bioactives In Stabilized Rice Bran Extract that Impart Anti-Inflammatory Benefits
3. NutraCea Forms Joint Ventures With HerbalScience to Develop Nutraceutical Extracts and Pharmaceutical Chemistries From Stabilized Rice Bran
4. Sensory Research Center Benefit Concert Yields Scholarships for Autistic Children
5. Fox Chase Cancer Center receives $8 million NIH grant to expand laboratory animal research facility
6. University of Georgia researchers show component of mothballs is present in deep-space clouds
7. Biomedical Research Centre developing enhanced cells as therapies
8. Video: Physical and Mental Health of U.S. Warfighter Is Focus of Military Health Research Forum
9. Researchers link inflammatory diseases to increased cardiovascular risk
10. AMR Research Analyst Named One of the Most Inspiring Individuals in Life Sciences by PharmaVOICE
11. Research Supports Improving Scoring of Costs and Benefits of Preventive Health Care to Better Inform Federal Budgetary Decisions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2009)... able to reverse some of the damage to their ... their cigarettes, according to research out of the University ... is published in the December 15 issue of the ... Critical Care Medicine . , "We found that exposure ... the epithelium, or lining, of the airways in the ...
(Date:12/6/2009)... that the loss of a key segment of DNA can ... to show that this kind of genetic alteration can cause ... , The study, led by Dr Sadaf Farooqi from the ... Trust Sanger Institute, looked at 300 children with severe obesity. ... types of mutation known as copy number variants (CNVs). CNVs ...
(Date:12/6/2009)... ORLEANS, Dec. 6 Sickle cell disease, ... blood cells, is one of the most common ... the world, including more than 70,000 Americans.(1) Research ... the American Society of Hematology highlights intriguing studies ... presents for children with this blood disorder, evaluations ...
(Date:12/6/2009)... LLP says dangerous substances such as asbestos have been found in ... ... NY (PRWEB) December 6, 2009 -- As parents shop for children,s ... of recalls due to lead paint or asbestos contamination, says a ... hospital emergency rooms each year due to toy-related injuries,” says Joseph ...
(Date:12/5/2009)... Type of Blood Cancer Is Most Challenging-- ... oncologists have identified specific genes, dubbed partner genes, that ... of leukemia in infants. By more accurately defining specific ... may benefit from particular treatments. ,, Oncologists also ...
Breaking Medicine News(10 mins):Health News:Quitting smoking can reverse asthma-inducing changes in lungs 2Health News:Genetic studies reveal new causes of severe obesity in childhood 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 3Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 4Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 5Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 6Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 7Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 8Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 9Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4
... follow her treacherous sister Notre Dame , honors ... Georgetown University continues to follow her treacherous ... pro-lifers to protest.On Wednesday, April 22, starting at 10 ... at Georgetown Law Center, McDonough Hall, 600 New Jersey ...
... 21 When Gundersen Lutheran Health System set out to ... 2 percent decrease that,s common at healthcare facilities. Instead, they,re ... than two years. That,s 9,600 metric tons of carbon dioxide ... of removing 1,631 cars from the road. The La Crosse, ...
... to families and businesses are increasing everywhere from the ... is why it is more important than ever to ... Holding down the costs of health care may seem ... challenge we can meet if all stakeholders - consumers, ...
... ISELIN, N.J., April 21 Pharmos Corporation ... a private placement of common stock and warrants. ... common stock and warrants exercisable for an additional 18,000,000 ... of $1,800,000. The exercise price of the warrants, ...
... LandfillsITASCA, Ill., April 21 JEWEL-OSCO, a leading Midwest ... Chicago this Earth Day (April 22nd) to launch the ... consumer use of reusable bags in order to save ... landfills. The "Choose to Reuse" program consists of Public ...
... and Blue Shield of Minnesota and its family of ... 2008. The organization reported an overall net loss of ... billion, with $8.0 billion paid to cover medical costs ... result of net realized capital losses in the organization,s ...
Other Medicine News:Health News:Anti Abortion Protesters will be at VP Biden Award at Georgetown Law School 2Health News:Innovative Program Will Help Lead Health System to Energy Independence by 2014 2Health News:Refuting Misconceptions About Health Insurance Mandates 2Health News:Pharmos Completes Private Placement - Raises $1.8 Million 2Health News:Pharmos Completes Private Placement - Raises $1.8 Million 3Health News:JEWEL-OSCO & FOX Chicago Launch 'Choose to Reuse' Bag Program 2Health News:JEWEL-OSCO & FOX Chicago Launch 'Choose to Reuse' Bag Program 3Health News:Blue Cross and Blue Shield of Minnesota Releases 2008 Financial Results 2
(Date:12/4/2009)... Dec. 4 Thermographic Diagnostic Imaging (TDI), part ... New Jersey continues to provide superior quality infrared ... TMJ and sinus regions to assist in the ... ,, Thermography utilizes infrared imaging cameras that ...
(Date:12/4/2009)... Ensure Emergency Deliveries are Transported ,, PHILADELPHIA, ... chapter of the American Red Cross are hard at ... that they endure that could potentially put Philadelphia,s blood ... on strike and set up a picket line yesterday ...
(Date:12/4/2009)... Dec. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ... teleconference and webcast. Principal investigators will discuss the ... myeloma, as featured at the 51st American Society of ... at 9:00 a.m. CT/10:00 a.m. ET on Monday, December ...
Breaking Medicine Technology:Discover Health Through Awareness 2Discover Health Through Awareness 3Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2Matthew Lehman of SPRI Clinical Trials Speaks On Designing Trials For Success At The Trout Group Investor Relations Seminar 12694 1Matthew Lehman of SPRI Clinical Trials Speaks On Designing Trials For Success At The Trout Group Investor Relations Seminar 12694 2Sinobiopharma Receives Trademark Approval and Authentication From Chinese Government For Its Tai Drug Series 49364 1Sinobiopharma Receives Trademark Approval and Authentication From Chinese Government For Its Tai Drug Series 49364 2North Shore LIJ Recruits New Chairman of Neurosurgery 49361 1North Shore LIJ Recruits New Chairman of Neurosurgery 49361 2
... Superdrugs Conference on ... ... a,leader in the development of small molecule anti-infective drugs, today,announced ... macrolide-related drug class, Bicyclolides, in the treatment,of methicillin-resistant Staphylococcus aureus ...
... ... Consortium -, BRISBANE, ... the clinical program for the company,s lead,product candidate, BSI-201, into glioblastoma ... ADP-ribose polymerase,(PARP) inhibitor in BiPar,s DNA repair portfolio, crosses the blood-brain,barrier, ...
Other Medicine Technology:Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, to Combat Hospital and Community Acquired Superbug Infections, Including MRSA 2Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, to Combat Hospital and Community Acquired Superbug Infections, Including MRSA 3BiPar Sciences Expands Clinical Program for BSI-201, a Novel DNA Repair Inhibitor, in Brain Cancer 2
Coronet Donor Punch Set - Unique design providing precise control and full visualization throughout the procedure. Corneal marking pen included....
Stainless Steel. Sterile. 2 pieces/box...
... Screw System has taken the best of ... combined them to offer a more complete ... and stainless steel. , ,The Asnis ... optimize surgical outcomes while simplifying procedures. This ...
The DePuy ACE 8.0mm Cannulated Cancellous Screw incorporates TiMAX to provide superior strength, fatigue resistance and a lower modulus of elasticity when compared to similar stainless steel devices....
Medicine Products: